Nuwellis Inc
NUWE
Company Profile
Business description
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Contact
12988 Valley View Road
Eden PrairieMN55344
USAT: +1 952 345-4200
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
38
Stocks News & Analysis
stocks
ASX tech share upgraded following AI contract wins
Strong demand for AI infrastructure drives fair value lift.
stocks
5 star fully franked ASX dividend payer
Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks
An undervalued stock to buy that even Warren Buffett likes
Trading at an 18% discount, this wide-moat stock is a rare find.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,969.20 | 82.60 | 0.93% |
| CAC 40 | 7,991.15 | 44.72 | -0.56% |
| DAX 40 | 25,303.97 | 95.24 | -0.37% |
| Dow JONES (US) | 51,349.92 | 131.59 | -0.26% |
| FTSE 100 | 10,637.39 | 0.68 | 0.01% |
| HKSE | 24,613.27 | 89.70 | 0.37% |
| NASDAQ | 26,797.54 | 22.84 | -0.09% |
| Nikkei 225 | 66,753.72 | 1,272.45 | 1.94% |
| NZX 50 Index | 13,834.39 | 150.76 | 1.10% |
| S&P 500 | 7,670.84 | 12.85 | -0.17% |
| S&P/ASX 200 | 8,789.30 | 80.00 | 0.92% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |